Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,861
datasets available to search
ShareScore release 0.9.0
Dataset results
6,861 results for “Animals”
FIG. 5 in Savoirs, observations et expériences sur l'animal exotique captif ( - siècle)
FIG. 5. — Homme nourrissant une autruche avec des clous et des fers à cheval. Psautier, dit « Queen Mary Psalter », 1310-1320. London, British Library, Ms Royal II B VII, f. 113v.
FIG. 2. — L in Savoirs, observations et expériences sur l'animal exotique captif ( - siècle)
FIG. 2. — L'éléphant du roi Henri III. Mathieu Paris, Liber additamentorum, c. 1255. London, British Library, Cotton M Nero D I, f. 169v.
FIG. 4 in Savoirs, observations et expériences sur l'animal exotique captif ( - siècle)
FIG. 4. — Autruche portant un fer à cheval dans son bec et surveillant l'éclosion de ses oeufs. Franz von Retz, Defensorium inviolatae virginitatis Mariae, Cologne, c. 1490? Dublin, Irish National Library, ms. 32,513, f. 30r.
FIG. 3 in Savoirs, observations et expériences sur l'animal exotique captif ( - siècle)
FIG. 3. — Lion captif ressuscitant ses petits par son souffle. Franz von Retz, Defensorium inviolatae virginitatis Mariae, Cologne, c. 1490? Dublin, Irish National Library, ms. 32,513, f. 31r.
FIG. 1. — L in Savoirs, observations et expériences sur l'animal exotique captif ( - siècle)
FIG. 1. — L'éléphant du roi Henri III et son gardien. Mathieu Paris, Cronica maiora, 2e moitié du XIIIe siècle. Cambridge, Corpus Christi College, Parker Library, CCC Ms 16, f. iir.
Presentation of The Australian Companion Animal Registry of Cancers (ACARCinom)
<p>With support from the Australian Research Data Commons (ARDC) through the Australian Data Partnership program, ACARCinom is the first Australia-wide registry of animal cancer occurrences that addresses the gaps in veterinary cancer data registries. ACARCinom aims to make a positive impact on cancer research for our pets. Having reliable data is crucial for understanding the patterns of cancer and for evaluating treatments in both animals and humans.</p><p>Five university veterinary schools and Australia's 2 leading veterinary pathology providers are partnering in the ACARCinom project: The University of Queensland, Queensland University of Technology, University of Sydney, Gribbles Veterinary Pathology, IDEXX, University of Adelaide, Murdoch University</p><p>By uniting the expertise and resources of these institutions, ACARCinom is poised to make significant advancements in understanding and combating cancer in dogs and cats. This project represents a remarkable collaboration that harnesses the power of data to unlock new insights and drive progress in the field of veterinary oncology.</p><p>This video explains how the ACARCinom Dashboard works and what its functionalities are. You can have access to the ACARCinom database at the following link: <a href="https://www.acarcinom.org.au/">acarcinom.org.au</a></p>
Appendices to the Roadmap for action for the project More Welfare: towards new risk assessment methodologies and harmonised animal welfare data in the EU
Open the record for dataset details and reuse information.
Red vision in animals is broadly associated with lighting environment but not types of visual task
<p>Red sensitivity is the exception rather than the norm in most animal groups. Among species with a long wavelength sensitive (LWS) photoreceptor, peak wavelength sensitivity (λ<sub>max</sub>) varies substantially and it is unclear whether this variation can be explained by visual tuning to the light environment or to visual tasks such as signalling or foraging. Here, we examine long wavelength sensitivity across a broad range of taxa showing diversity in LWS photoreceptor λ<sub>max</sub>: insects, crustaceans, arachnids, amphibians, reptiles, fish, sharks and rays. We identified 161 species with a LWS photoreceptor (λ<sub>max</sub> ≥ 550 nm). We found evidence supporting visual tuning to the light environment: terrestrial species had longer λ<sub>max</sub> than aquatic species, and of these, species from turbid shallow waters had longer λmax than those from clear or deep waters. Of the terrestrial species, diurnal species had longer λ<sub>max</sub> than nocturnal species, but we did not detect any differences across terrestrial habitats (closed, intermediate or open). We found no association with proxies for visual tasks such as having red morphological features or utilising flowers or coral reefs. These results support the emerging consensus that, in general, visual systems are adapted to broad range of tasks, rather than tuned to certain tasks.</p>
Fig.ç2.Ec hinoderes ohtsukai sp. nov., camera lucida drawings. A, B, Holotype, male (ZIHU 3976), entire animal, dorsal and ventral view, respectively; C, D, allotype, female (ZIHU 3977), segments 9–11, dorsal and ventral view, respectively. Abbreviations: dss, droplet-shaped sensory spot; gco1, glandular cell outlet type I; gco2, modi ed glandular cell outlet type II; ldt, laterodorsal tubule; lts, lateral terminal spine; lvt, lateroventral tubule; mds, middorsal spine; ne, neck; ps, penile spine; rss, rounded sensory spot; si, sieve plate. in A New Brackish-water Species of Echinoderes (Kinorhyncha: Cyclorhagida) from the Seto Inland Sea, Japan
Fig.ç2.Ec hinoderes ohtsukai sp. nov., camera lucida drawings. A, B, Holotype, male (ZIHU 3976), entire animal, dorsal and ventral view, respectively; C, D, allotype, female (ZIHU 3977), segments 9–11, dorsal and ventral view, respectively. Abbreviations: dss, droplet-shaped sensory spot; gco1, glandular cell outlet type I; gco2, modi ed glandular cell outlet type II; ldt, laterodorsal tubule; lts, lateral terminal spine; lvt, lateroventral tubule; mds, middorsal spine; ne, neck; ps, penile spine; rss, rounded sensory spot; si, sieve plate.
Piecewise continuous sampling: a method for minimizing bias and sampling effort for estimated metrics of animal behavior
<p>Capturing qualitative features of animal behavior requires recording occurrences of behavior over time. Continuous sampling is best for capturing brief behaviors, but can be very time consuming. Instantaneous sampling can reduce the amount of labor required, but can miss short-duration behaviors. We therefore synthesized these techniques by continuously sampling during randomly scattered time intervals; a technique we call piecewise continuous sampling. To optimize and test the efficacy of this technique, we collected a continuous behavioral dataset of harvester ant workers, and then we developed a protocol to estimate the amount of sampling time necessary to reconstruct the proportion of time animals spend in different behavioral states. This protocol finds the sample size needed for the variance of the sample to converge on the variation of the population. We then divided this estimated time into equal-duration intervals that were randomly distributed across the entire continuous dataset. Finally, we calculated both time-dependent and time-independent error from this sample. We found that 4 to 16 sampling intervals minimize both types of error simultaneously. This finding was robust to differences in underlying behavior and was validated with simulations, implying that this method could be used for many types of organisms.</p>
Dataset for Evaluating habitat-specific interference in automated radio telemetry systems: implications for animal movement studies
<h1>Abstract </h1> <p>Automated radio telemetry systems have become a popular and invaluable tool in tracking the activity and movement of wild animals. However, many environmental conditions can hinder accuracy when tracking with this technology. For instance, study sites may contain multiple habitat types, each habitat uniquely affecting the signal strength received from tagged species. To investigate the influence of a structurally diverse study site on an automated radio telemetry system, we conducted this project at a restored and managed pine barren habitat that consisted of a mix of mature pitch pine, treated pitch pine, scrub oak, and hardwood forests. This site, Montague Plains Wildlife Management Area, Montague, Massachusetts, is also a known breeding ground for Eastern whip-poor-will (Antrostomus vociferus). To measure the relationship of radio signal strength with distance across each habitat, we used radio telemetry equipment manufactured by Cellular Tracking Technologies. We produced negative exponential decay functions measuring radio signal strength over distance and tested for differences among habitat types on radio signal strength (RSS). We found that decay function parameters significantly differed by habitat type, prompting us to investigate if accounting for these differences improved location estimate accuracy. To test this, we estimated known locations using trilateration methods with and without habitat calibration. Comparing these tests indicates that habitat-specific adjustments significantly improved location accuracy. Lastly, we visualized estimated RSS-based locations of one week of whip-poor-will data and compared them to GPS data generated from the same individual. Previous studies have accounted for types of environmental interference (like elevation) in the field but have avoided incorporating habitat-specific factors by working with node networks covering a relatively small area, but in this study, we examined the potential to scale up for larger areas and in more complex habitats.</p> <p> </p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Croatia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Croatia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Croatian Food Agency</p> <p>VMPR_2022 – Croatian Food Agency</p> <p>VMPR_2021 – Croatian Food Agency</p> <p>VMPR_2020 – Croatian Food Agency</p> <p>VMPR_2019 – Croatian Food Agency</p> <p>VMPR_2018 – Croatian Food Agency</p> <p>VMPR_2017 – Croatian Food Agency</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Ireland
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Ireland. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2022 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2021 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2020 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2019 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2018 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2017 – Department of Agriculture, Food and the Marine</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Finland
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Finland. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Finnish Food Authority</p> <p>VMPR_2022 – Finnish Food Authority</p> <p>VMPR_2021 – Finnish Food Authority</p> <p>VMPR_2020 – Finnish Food Authority</p> <p>VMPR_2019 – Finnish Food Authority</p> <p>VMPR_2018 – Finnish Food Authority</p> <p>VMPR_2017 – Finnish Food Authority</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Greece
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Greece. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Ministry of Rural Development and Food</p> <p>VMPR_2022 – Ministry of Rural Development and Food</p> <p>VMPR_2021 – Ministry of Rural Development and Food</p> <p>VMPR_2020 – Ministry of Rural Development and Food</p> <p>VMPR_2019 – Ministry of Rural Development and Food</p> <p>VMPR_2018 – Ministry of Rural Development and Food</p> <p>VMPR_2017 – Ministry of Rural Development and Food</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Luxembourg
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Luxembourg. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Veterinary Service Administration</p> <p>VMPR_2022 – Veterinary Service Administration</p> <p>VMPR_2021 – Veterinary Service Administration</p> <p>VMPR_2020 – Veterinary Service Administration</p> <p>VMPR_2019 – Veterinary Service Administration</p> <p>VMPR_2018 – Veterinary Service Administration</p> <p>VMPR_2017 – Veterinary Service Administration</p> <p> </p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Cyprus
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Cyprus. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – State General Laboratory - Ministry of Health</p> <p>VMPR_2022 – State General Laboratory - Ministry of Health</p> <p>VMPR_2021 – State General Laboratory - Ministry of Health</p> <p>VMPR_2020 – State General Laboratory - Ministry of Health</p> <p>VMPR_2019 – State General Laboratory - Ministry of Health</p> <p>VMPR_2018 – State General Laboratory - Ministry of Health</p> <p>VMPR_2017 – State General Laboratory - Ministry of Health</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Latvia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Latvia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2022 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2021 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2020 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2019 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2018 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2017 – Institute of Food Safety, Animal Health and Environment</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Slovakia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Slovakia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2022 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2021 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2020 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2019 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2018 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2017 – State Veterinary and Food Administration of the Slovak Republic</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - The Netherlands
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of The Netherlands. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Netherlands Food and Consumer Product Safety Authority</p> <p>VMPR_2022 – Netherlands Food and Consumer Product Safety Authority</p> <p>VMPR_2021 – Netherlands Food and Consumer Product Safety Authority</p> <p>VMPR_2020 – National Institute for Public Health and the Environment</p> <p>VMPR_2019 – National Institute for Public Health and the Environment </p> <p>VMPR_2018 – National Institute for Public Health and the Environment</p> <p>VMPR_2017 – National Institute for Public Health and the Environment</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.